ClinConnect ClinConnect Logo
Search / Trial NCT05760573

The Ready and Healthy for Kindergarten Study

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Feb 27, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Early Literacy Language Development Famliy Literacy Bilingualism Community Engagement

ClinConnect Summary

Education is a critical social determinant of health (SDOH). Latino dual language learners face large gaps in school readiness, which perpetuate inequities in academic achievement and subsequent health. Investigators developed an online family wellness program that uses anticipatory guidance on health topics intrinsically important to school readiness (e.g., nutrition, physical activity) to introduce basic language and literacy skills to Latino dual language learners, a fast- growing and particularly high-risk group, and their families. The online family wellness program was developed throu...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • primary caregiver of a child entering Kindergarten (4-6 years old),
  • primary caregiver identifies as Hispanic/Latino/Latinx,
  • family speaks Spanish at home,
  • cell phone ownership,
  • willing to receive text messages,
  • ability to pick up program materials locally, and
  • willing to accept randomization
  • Exclusion Criteria:
  • -Individuals unable to provide informed consent

About Rutgers, The State University Of New Jersey

Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.

Locations

New Brunswick, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Manuel E Jimenez, MD, MS

Principal Investigator

Rutgers University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials